Mature Americans follow drug ads
A new survey by Rx Remedy Information Services, a Mercerville-NJ provider of syndicated information on consumer-reported healthcare, reveals that the majority of the mature audience (50 years and older) for healthcare ads are sophisticated consumers of healthcare information.
A new survey by Rx Remedy Information Services, a Mercerville-NJ provider of syndicated information on consumer-reported healthcare, reveals that the majority of the mature audience (50 years and older) for healthcare ads are sophisticated consumers of healthcare information.
The ongoing panel of mature adults reveals new information on the effectiveness of healthcare advertising. More than half the panelists pay close attention to pharmaceutical advertising for prescription drugs, and 49% think such ads provide helpful information. By comparison, only 23% of baby boomers and their elders rely on family and friends for information on new healthcare products and services.
"Analyzing responses from the same group of people over time provides insights into the challenges of communicating a pharmaceutical value proposition to this willing yet unconvinced market," said Robert J. Enck, division president of Rx Remedy Information Services. "For example, we found that nearly half our panelists find the information in drug ads to be complex and confusing. The implication may be that pharmaceutical companies need to deepen their understanding of consumers' information needs and their actual behavior in order to redefine messages that resonate with the [mature] healthcare consumer." PR
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
